1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Chronic Kidney Disease(CKD): new trials by email Literature Review of Chronic Kidney Disease(CKD) trials Research Report on Chronic Kidney Disease(CKD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia AP301, Sevelamer carbonate (Renvela®), AP301 Low Dose - ESRD (End Stage Renal Disease), Chronic Kidney Disease(CKD) | Phase 3 | Completed | Alebund Pharmaceuticals | 474 | 2023-06-12 | 2025-11-17 |
| Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease Antihypertensive algorithm, Standard of care - Chronic Kidney Disease(CKD), Uncontrolled Hypertension | Phase 3 | Recruiting | University Hospital, Tours | 720 | 2023-03-28 | 2026-08-03 |
Renal Insufficiency, Chronic (2) · Hyperphosphatemia (1)
Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Phosphorus Metabolism Disorders (1)
Sevelamer (1) · Standard of Care (1)
Alebund Pharmaceuticals (1) · University Hospital, Tours (1)
China (1) · France (1)